Mahoney Michael F 4
Research Summary
AI-generated summary
Boston Scientific (BSX) CEO Michael Mahoney Exercises Awards, Sells Shares
What Happened
Michael F. Mahoney (Chairman, President & CEO) had performance-based awards vest and were converted into shares between Feb 13–16, 2026. The filing shows two awards of 132,190 shares each (performance share units) and conversions/exercises of derivatives totaling 41,621 shares (codes A and M). To satisfy tax withholding obligations (code F), 147,954 shares were surrendered/issued at $74.73 per share, producing proceeds of $11,056,602. These were routine tax-withholding dispositions rather than an open-market investment sale.
Key Details
- Transaction dates: Feb 13, Feb 14 and Feb 16, 2026. Withholding price: $74.73 per share. Total proceeds from withheld shares: $11,056,602.
- Shares shown granted/awarded: two grants of 132,190 shares each (total 264,380). Derivative conversions/exercises acquired: 41,621 shares. Shares withheld/disposed for taxes: 147,954.
- Net shares retained after withholding (approx.): 306,001 acquired − 147,954 withheld ≈ 158,047 net new shares added to holdings.
- Footnotes: F1–F2 — the two 2023 performance share programs vested based on three‑year performance through Dec 31, 2025; F3–F6 — restricted stock unit mechanics and installment issuance schedules.
- Filing: Report filed Feb 18, 2026 covering the Feb 13–16 transactions. No late‑filing flag was indicated in the provided excerpt.
Context
- Code meanings: A = award/grant, M = exercise/conversion of derivative (conversion of PSU/RSU to shares), F = payment of exercise price or tax withholding (shares surrendered to cover taxes).
- This appears to be a standard vesting/conversion of earned performance awards with shares withheld to meet tax obligations (a form of cashless settlement), not a voluntary open-market sale for investment or diversification.
- For retail investors: awards converting into shares increase insider ownership; tax-withholding sells are routine and don’t necessarily signal personal views on the stock.